FDA announces OPQ reorganization to alleviate ‘long-standing pain points’
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)PharmaceuticalsProduct developmentProduct LifecycleQuality Assurance and ControlRegulatory Intelligence/PolicyUnited States